#United States #New York #Opioid Crisis #Ensysce Biosciences #Dr. Lynn Kirkpatrick

Tackling the Opioid Crisis: Insights from Ensysce Biosciences and Creighton University

In a recent interview with Today's Marketplace, Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences, and Dr. Neel Pathak, Program Director at Creighton University, shed light on the ongoing challenges posed by the opioid crisis and the innovative solutions being developed to address these issues.

The Current State of the Opioid Crisis

The opioid crisis continues to be a pressing issue in the United States, with millions of patients relying on these medications for pain management. Dr. Pathak noted that despite the severe risks associated with opioid use—including addiction and overdose—many individuals have no alternatives for effective pain relief, particularly in cases of chronic pain, post-surgical recovery, and cancer treatment. Shockingly, approximately three million patients each year find themselves dependent on opioids.

This dependency has not only health implications but economic ones as well, with the healthcare system incurring nearly a trillion dollars annually due to the consequences of opioid misuse. The need for effective pain management solutions that minimize these risks is more critical than ever.

Innovative Solutions: 'Clever Chemistry'

In the interview, Dr. Kirkpatrick introduced the concept of 'clever chemistry'—the foundation of Ensysce's research and development efforts. This innovative approach aims to re-engineer opioids to enhance their safety profile. Unlike conventional methods attempted by other companies, which have largely been unsuccessful in creating alternative painkillers effective as opioids, Ensysce is modifying opioids to reduce the potential for abuse while maintaining their efficacy.

Dr. Kirkpatrick stated, "Our team uses what I like to call 'clever chemistry' to create the next generation of opioids." The focus is on ensuring that modified opioids remain inactive unless consumed orally. This significantly reduces the likelihood of recreational misuse.

In addition to making these opioids safer, the development process includes built-in deterrents against overdose. For example, the new formulation prevents medication release if dosages exceed the prescribed amount, providing physicians and patients with assurance regarding its use.

FDA Fast Track and Breakthrough Designations

Ensysce's efforts have garnered attention from regulatory authorities, with their chemically modified oxycodone receiving both 'Fast Track' and 'Breakthrough Therapy' designations from the FDA. Dr. Kirkpatrick expressed enthusiasm regarding these acknowledgments, as they highlight the urgent medical need for safer opioid alternatives and the promising advancements being made in this area.

The Role of Today's Marketplace

Dr. Kirkpatrick emphasized the importance of platforms like Today's Marketplace in disseminating vital information on this pressing topic. The series of insightful interviews aims to bridge the gap between business solutions and academic insights. Dr. Kirkpatrick pointed out that TMP provides a unique opportunity to reach a national audience to discuss the dual challenges faced in the U.S.: the necessity for effective opioid medications and the regulatory environment that seeks to mitigate opioid misuse.

Conclusion

As our understanding of the opioid crisis evolves, the commitment from innovative companies like Ensysce Biosciences to create safer, more effective opioids is encouraging. Interviews such as the one with Dr. Kirkpatrick and Dr. Pathak not only highlight the critical advancements being made but also remind us of the urgent need for solutions that prioritize patient safety while addressing the public health challenges posed by opioids. For further information about Ensysce Biosciences and their methodologies, visit their website at ensysce.com.

About Ensysce Biosciences

Ensysce is a pioneering entity engaged in developing unique oral drug delivery solutions designed to enhance patient safety and care by preventing abuse and overdose.

About Creighton University

Creighton University, located in Omaha, Nebraska, embodies the essence of a Jesuit, Catholic education, enrolling over 7,000 students across its undergraduate and professional schools. It focuses on bridging fields like health, law, and business to cultivate a more just world.

About Today's Marketplace

Today's Marketplace is a platform showcasing significant insights through interviews filmed at notable financial market sites. It serves to provide transparency and increase awareness around underreported issues through authoritative media exposure.